Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

1.

Novel mutations in neuroendocrine carcinoma of the breast: possible therapeutic targets.

Ang D, Ballard M, Beadling C, Warrick A, Schilling A, O'Gara R, Pukay M, Neff TL, West RB, Corless CL, Troxell ML.

Appl Immunohistochem Mol Morphol. 2015 Feb;23(2):97-103. doi: 10.1097/PDM.0b013e3182a40fd1.

PMID:
25679062
2.

Pemetrexed in patients with thymic malignancies previously treated with chemotherapy.

Liang Y, Padda SK, Riess JW, West RB, Neal JW, Wakelee HA.

Lung Cancer. 2015 Jan;87(1):34-8. doi: 10.1016/j.lungcan.2014.11.006. Epub 2014 Nov 15.

PMID:
25443273
3.

Diffuse high intensity PD-L1 staining in thymic epithelial tumors.

Padda SK, Riess JW, Schwartz EJ, Tian L, Kohrt HE, Neal JW, West RB, Wakelee HA.

J Thorac Oncol. 2015 Mar;10(3):500-8. doi: 10.1097/JTO.0000000000000429.

PMID:
25402569
4.

Fingerprints of Epstein-Barr virus in nasopharyngeal carcinoma.

West RB.

Nat Genet. 2014 Aug;46(8):809-10. doi: 10.1038/ng.3038. No abstract available.

PMID:
25070800
5.

A shared transcriptional program in early breast neoplasias despite genetic and clinical distinctions.

Brunner AL, Li J, Guo X, Sweeney RT, Varma S, Zhu SX, Li R, Tibshirani R, West RB.

Genome Biol. 2014 May 23;15(5):R71. doi: 10.1186/gb-2014-15-5-r71.

6.

Identification of recurrent SMO and BRAF mutations in ameloblastomas.

Sweeney RT, McClary AC, Myers BR, Biscocho J, Neahring L, Kwei KA, Qu K, Gong X, Ng T, Jones CD, Varma S, Odegaard JI, Sugiyama T, Koyota S, Rubin BP, Troxell ML, Pelham RJ, Zehnder JL, Beachy PA, Pollack JR, West RB.

Nat Genet. 2014 Jul;46(7):722-5. doi: 10.1038/ng.2986. Epub 2014 May 25. Erratum in: Nat Genet. 2015 Jan;47(1):97.

PMID:
24859340
7.

Stromal responses among carcinomas--response.

West RB, van de Rijn M, Chen JL.

Clin Cancer Res. 2014 Mar 1;20(5):1397. doi: 10.1158/1078-0432.CCR-13-3238. No abstract available.

8.

Novel Mutations in Neuroendocrine Carcinoma of the Breast: Possible Therapeutic Targets.

Ang D, Ballard M, Beadling C, Warrick A, Schilling A, O'Gara R, Pukay M, Neff TL, West RB, Corless CL, Troxell ML.

Diagn Mol Pathol. 2014 Feb 24. [Epub ahead of print]

PMID:
24569783
9.

Next generation sequencing-based expression profiling identifies signatures from benign stromal proliferations that define stromal components of breast cancer.

Guo X, Zhu SX, Brunner AL, van de Rijn M, West RB.

Breast Cancer Res. 2013 Dec 17;15(6):R117. doi: 10.1186/bcr3586.

10.

Stromal signatures in endometrioid endometrial carcinomas.

Espinosa I, Catasus L, D' Angelo E, Mozos A, Pedrola N, BĂ©rtolo C, Ferrer I, Zannoni GF, West RB, van de Rijn M, Matias-Guiu X, Prat J.

Mod Pathol. 2014 Apr;27(4):631-9. doi: 10.1038/modpathol.2013.131. Epub 2013 Nov 22.

11.

Discovery of recurrent structural variants in nasopharyngeal carcinoma.

Valouev A, Weng Z, Sweeney RT, Varma S, Le QT, Kong C, Sidow A, West RB.

Genome Res. 2014 Feb;24(2):300-9. doi: 10.1101/gr.156224.113. Epub 2013 Nov 8.

12.

Inference of tumor phylogenies with improved somatic mutation discovery.

Salari R, Saleh SS, Kashef-Haghighi D, Khavari D, Newburger DE, West RB, Sidow A, Batzoglou S.

J Comput Biol. 2013 Nov;20(11):933-44. doi: 10.1089/cmb.2013.0106.

13.

Neuregulin autocrine signaling promotes self-renewal of breast tumor-initiating cells by triggering HER2/HER3 activation.

Lee CY, Lin Y, Bratman SV, Feng W, Kuo AH, Scheeren FA, Engreitz JM, Varma S, West RB, Diehn M.

Cancer Res. 2014 Jan 1;74(1):341-52. doi: 10.1158/0008-5472.CAN-13-1055. Epub 2013 Oct 31.

14.

MAST2 and NOTCH1 translocations in breast carcinoma and associated pre-invasive lesions.

Clay MR, Varma S, West RB.

Hum Pathol. 2013 Dec;44(12):2837-44. doi: 10.1016/j.humpath.2013.08.001. Epub 2013 Oct 18.

PMID:
24140425
15.

Molecular pathological analysis of sarcomas using paraffin-embedded tissue: current limitations and future possibilities.

van de Rijn M, Guo X, Sweeney RT, Beck AH, West RB.

Histopathology. 2014 Jan;64(1):163-70. doi: 10.1111/his.12290. Epub 2013 Nov 25. Review.

PMID:
24107169
16.

Integrative bioinformatics links HNF1B with clear cell carcinoma and tumor-associated thrombosis.

Cuff J, Salari K, Clarke N, Esheba GE, Forster AD, Huang S, West RB, Higgins JP, Longacre TA, Pollack JR.

PLoS One. 2013 Sep 9;8(9):e74562. doi: 10.1371/journal.pone.0074562. eCollection 2013.

17.

Stromal responses among common carcinomas correlated with clinicopathologic features.

Chen JL, Espinosa I, Lin AY, Liao OY, van de Rijn M, West RB.

Clin Cancer Res. 2013 Sep 15;19(18):5127-35. doi: 10.1158/1078-0432.CCR-12-3127. Epub 2013 Jun 26.

18.

Breakpoint analysis of transcriptional and genomic profiles uncovers novel gene fusions spanning multiple human cancer types.

Giacomini CP, Sun S, Varma S, Shain AH, Giacomini MM, Balagtas J, Sweeney RT, Lai E, Del Vecchio CA, Forster AD, Clarke N, Montgomery KD, Zhu S, Wong AJ, van de Rijn M, West RB, Pollack JR.

PLoS Genet. 2013 Apr;9(4):e1003464. doi: 10.1371/journal.pgen.1003464. Epub 2013 Apr 25.

19.

Human papillomavirus 16 detected in nasopharyngeal carcinomas in white Americans but not in endemic Southern Chinese patients.

Lin Z, Khong B, Kwok S, Cao H, West RB, Le QT, Kong CS.

Head Neck. 2014 May;36(5):709-14. doi: 10.1002/hed.23362. Epub 2013 Oct 26.

PMID:
23616441
20.

Desktop transcriptome sequencing from archival tissue to identify clinically relevant translocations.

Sweeney RT, Zhang B, Zhu SX, Varma S, Smith KS, Montgomery SB, van de Rijn M, Zehnder J, West RB.

Am J Surg Pathol. 2013 Jun;37(6):796-803. doi: 10.1097/PAS.0b013e31827ad9b2.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk